Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection

被引:9
作者
Macaluso, Fabio Salvatore [1 ]
Maida, Marcello [1 ]
Camma, Calogero [1 ]
Cabibi, Daniela [2 ]
Alessi, Nicola [1 ]
Cabibbo, Giuseppe [1 ]
Di Marco, Vito [1 ]
Craxi, Antonio [1 ]
Petta, Salvatore [1 ]
机构
[1] Univ Palermo, Dipartimento Biochim Med Interna & Specialist, Sez Gastroenterol, Palermo, Italy
[2] Univ Palermo, Cattedra Anat Patol, Palermo, Italy
关键词
BLEP; Fibrosis; Evaluation; Cirrhosis; CHRONIC VIRAL-HEPATITIS; INSULIN-RESISTANCE; FIBROSIS; RELIABILITY; ULTRASOUND; DISEASE; BIOPSY; IMPACT;
D O I
10.1016/j.cgh.2013.09.059
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Few studies have evaluated the accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C. We assessed its accuracy in detecting steatosis and factors that affect its diagnostic performance in consecutive patients with chronic hepatitis C virus genotype 1 infection. METHODS: We analyzed data from 515 patients with chronic hepatitis C, confirmed by liver biopsy, assessing anthropometric, biochemical, metabolic, virologic, and ultrasonography features. Transient elastography was performed to measure liver stiffness. Steatosis was identified with ultrasonography based on detection of a bright liver echo pattern. RESULTS: Ultrasonography identified steatosis in 5% or more of parenchyma of the liver with 63.6% sensitivity, 90.4% specificity, an 87.5% positive predictive value (PPV), and a 70.3% negative predictive value (NPV). The higher the degree of steatosis (based on histology analysis), the higher the sensitivity values and NPVs (up to values of 75.3% and 93.8%, respectively, for steatosis in >= 30% of liver), and the lower the specificity values and PPVs (down to values of 69.8% and 31.7% for steatosis in >= 30% of liver, respectively). Body mass index of 30 kg/m(2) or greater (odds ratio, 2.761; 95% confidence interval, 1.156-6.595; P = .02) and liver stiffness measurements of 8.9 kPa or higher (odds ratio, 3.128; 95% confidence interval, 1.715-5.706; P < .001) were independent risk factors for false-negative results from ultrasonography when there was 5% or more steatosis, as well as when there was 10% or more, 20% or more, or 30% or more steatosis. CONCLUSIONS: Ultrasonography detects steatosis with low levels of accuracy in patients with chronic hepatitis C virus genotype 1 infection; it has low NPVs for amounts of steatosis of 5% or more and low PPVs for livers with moderate-severe amounts. Higher body mass indexes and liver stiffness measurements are associated with false-negative results in steatosis detection by ultrasonography.
引用
收藏
页码:878 / U209
页数:8
相关论文
共 50 条
  • [41] Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection
    Miyasaka, Akio
    Yoshida, Yuichi
    Murakami, Akihiko
    Hoshino, Takao
    Sawara, Kei
    Numao, Hiroshi
    Takikawa, Yasuhiro
    HEALTH SCIENCE REPORTS, 2022, 5 (01)
  • [42] Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals
    Akuta, Norio
    Kobayashi, Masahiro
    Suzuki, Fumitaka
    Sezaki, Hitomi
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Mariko
    Saitoh, Satoshi
    Suzuki, Yoshiyuki
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    ONCOLOGY, 2016, 91 (06) : 341 - 347
  • [43] Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy
    Tada, T.
    Kumada, T.
    Toyoda, H.
    Sone, Y.
    Takeshima, K.
    Ogawa, S.
    Goto, T.
    Wakahata, A.
    Nakashima, M.
    Nakamuta, M.
    Tanaka, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (07) : 1012 - 1022
  • [44] Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients
    Petta, S.
    Grimaudo, S.
    Marco, V. D.
    Scazzone, C.
    Macaluso, F. S.
    Camma, C.
    Cabibi, D.
    Pipitone, R.
    Craxi, A.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (07) : 486 - 493
  • [45] High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis
    Petta, Salvatore
    Tripodo, Claudio
    Grimaudo, Stefania
    Cabibi, Daniela
    Camma, Calogero
    Di Cristina, Antonietta
    Di Marco, Vito
    Di Vita, Gaetano
    Ingrao, Sabrina
    Mazzola, Alessandra
    Marchesini, Giulio
    Pipitone, Rosaria
    Craxi, Antonio
    DIGESTIVE AND LIVER DISEASE, 2011, 43 (05) : 404 - 410
  • [46] Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection
    Jacobson, Ira M.
    Davis, Gary L.
    El-Serag, Hashem
    Negro, Francesco
    Trepo, Christian
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (11) : 924 - 933
  • [47] Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response
    Kobayashi, Natsuko
    Iijima, Hiroko
    Tada, Toshifumi
    Kumada, Takashi
    Yoshida, Masahiro
    Aoki, Tomoko
    Nishimura, Takashi
    Nakano, Chikage
    Takata, Ryo
    Yoh, Kazunori
    Ishii, Akio
    Takashima, Tomoyuki
    Sakai, Yoshiyuki
    Aizawa, Nobuhiro
    Nishikawa, Hiroki
    Ikeda, Naoto
    Iwata, Yoshinori
    Enomoto, Hirayuki
    Hirota, Seiichi
    Fujimoto, Jiro
    Nishiguchi, Shuhei
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (05) : 546 - 551
  • [48] Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan
    Toyoda, Hidenori
    Atsukawa, Masanori
    Takaguchi, Koichi
    Senoh, Tomonori
    Michitaka, Kojiro
    Hiraoka, Atsushi
    Fujioka, Shinichi
    Kondo, Chisa
    Okubo, Tomomi
    Uojima, Haruki
    Tada, Toshifumi
    Yoneyama, Hirohito
    Watanabe, Tsunamasa
    Asano, Toru
    Ishikawa, Toru
    Tamai, Hideyuki
    Abe, Hiroshi
    Kato, Keizo
    Tsuji, Kunihiko
    Ogawa, Chikara
    Shimada, Noritomo
    Iio, Etsuko
    Deguchi, Akihiro
    Itobayashi, Ei
    Mikami, Shigeru
    Moriya, Akio
    Okubo, Hironao
    Tani, Joji
    Tsubota, Akihito
    Tanaka, Yasuhito
    Masaki, Tsutomu
    Iwakiri, Katsuhiko
    Kumada, Takashi
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (12) : 1276 - 1284
  • [49] Increased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis
    Franceschini, B.
    Russo, C.
    Dioguardi, N.
    Grizzi, F.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (08) : 549 - 555
  • [50] Impact of hepatitis E virus seropositivity on chronic liver disease in cancer patients with hepatitis C virus infection
    Kyvernitakis, Andreas
    Taremi, Mahnaz
    Blechacz, Boris
    Hwang, Jessica
    Jiang, Ying
    Mahale, Parag
    Torres, Harrys A.
    HEPATOLOGY RESEARCH, 2015, 45 (11) : 1146 - 1151